Journal article · 2026
Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial
Nature Medicine · Published 8 November 2026 · DOI 10.1038/s41591-026-04762-3
In brief
“Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial” is a 2026 journal article by Barry A. Borlaug and 7 co-authors, published in Nature Medicine. OpenAlex counts 0 citations as of 16 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 26
- Authors
- 8
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Borlaug, B. A., Jensen, M. D., Packer, M., Reddy, Y. N., Harada, T., Ghanbari, F., Johnson, P. W., & Carter, R. E. (2026). Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04762-3
MLA 9
Borlaug, Barry A., et al. “Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial.” Nature Medicine, 2026. https://doi.org/10.1038/s41591-026-04762-3.
Chicago
Borlaug, Barry A., Michael D. Jensen, Milton Packer, Yogesh N.V. Reddy, Tomonari Harada, Fahime Ghanbari, Patrick W. Johnson, and Rickey E. Carter. 2026. “Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial.” Nature Medicine. https://doi.org/10.1038/s41591-026-04762-3.
Harvard
Borlaug, B. A. et al. (2026) ‘Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial’, Nature Medicine. doi:10.1038/s41591-026-04762-3.
IEEE
B. A. Borlaug et al., “Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial,” Nature Medicine, 2026, doi: 10.1038/s41591-026-04762-3.
BibTeX
@article{borlaug2026hemodynamic,
title = {{Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial}},
author = {Borlaug, Barry A. and Jensen, Michael D. and Packer, Milton and Reddy, Yogesh N.V. and Harada, Tomonari and Ghanbari, Fahime and Johnson, Patrick W. and Carter, Rickey E.},
journal = {Nature Medicine},
year = {2026},
doi = {10.1038/s41591-026-04762-3},
url = {https://doi.org/10.1038/s41591-026-04762-3}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- semaglutide
- heart failure with preserved ejection fraction
- obesity
- GLP-1 receptor agonists
- pulmonary capillary wedge pressure
- cardiac congestion
- low-intensity exercise
- hemodynamics
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Borlaug, B. A., Jensen, M. D., Packer, M., Reddy, Y. N., Harada, T., Ghanbari, F., Johnson, P. W., & Carter, R. E. (2026). Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04762-3
How many times has this paper been cited?
0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Barry A. Borlaug, Michael D. Jensen, Milton Packer, Yogesh N.V. Reddy, Tomonari Harada, Fahime Ghanbari, Patrick W. Johnson, Rickey E. Carter.
What is the DOI of this paper?
10.1038/s41591-026-04762-3, permanently at https://doi.org/10.1038/s41591-026-04762-3. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.